Key result
Complete resection of pulmonary metastases from soft-tissue sarcoma yielded a median survival of 21 months, with a 5-year survival of 22% for patients with ≤5 metastases versus 21% for ≥6 metastases.
Why the study?
Does resection of lung metastases from soft-tissue sarcomas improve survival in patients with pulmonary metastases?
Cohort (n=78)
Does resection of lung metastases from soft-tissue sarcomas improve survival in patients with pulmonary metastases?
Absolute Event Rate: 22% vs 21%
Complete resection of pulmonary metastases from soft-tissue sarcoma can prolong survival, with fewer metastases showing a trend toward longer disease-free survival.
No takes yet. Share an insight, caveat, or question.
Pulmonary metastasectomy may be considered in selected patients; leaves open survival benefit versus nonoperative management in randomized trials.
Gary T. Verazin (1992) conducted a cohort in Lung metastases from soft-tissue sarcomas (n=78). Resection of lung metastases vs. Incomplete resection or ≥6 metastases was evaluated on 5-year overall survival (≤5 vs ≥6 metastases). Complete resection of pulmonary metastases from soft-tissue sarcoma yielded a median survival of 21 months, with a 5-year survival of 22% for patients with ≤5 metastases versus 21% for ≥6 metastases.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: